Ajanta Pharma Ltd. Conference Calls and Earnings Call Transcripts

08 May 2026

3338.60

-2.46%

Earnings Call

Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pls find enclosed Written Transcript of Earnings Call held on 5th May 2026.

05 May 2026

3338.60

-2.46%

Ajanta Pharma Results Earnings Call for Q4FY26 & Full Year

Conference Call with Ajanta Pharma Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

05 Feb 2026

3338.60

-2.46%

Earnings Call

Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pls find enclosed Earnings Call Transcript

30 Jan 2026, 05:50PM

3338.60

-2.46%

Ajanta Pharma Results Earnings Call for Q3FY26

Conference Call with Ajanta Pharma Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.

06 Nov 2025

3338.60

-2.46%

Earnings Call

Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pls find enclosed Written Transcript of Earnings Call

03 Nov 2025

3338.60

-2.46%

Ajanta Pharma Results Earnings Call for Q2FY26

Conference Call with Ajanta Pharma Management and Analysts on Q2FY26 Performance and Outlook. Listen to the full earnings transcript.

31 Jul 2025, 11:06AM

3338.60

-2.46%

Earnings Call

Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pls find enclosed Written Transcript of Earnings Call held on 28th July 2025.

28 Jul 2025

3338.60

-2.46%

Ajanta Pharma Results Earnings Call for Q1FY26

Conference Call with Ajanta Pharma Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.

05 May 2025

3338.60

-2.46%

Earnings Call

Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

PFA Earnings Call Transcript

30 Apr 2025, 06:22PM

3338.60

-2.46%

Ajanta Pharma Results Earnings Call for Q4FY25 & Full Year

Conference Call with Ajanta Pharma Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.